Sort
30,917 grants matching “tumor microenvironment”
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$572,168Dan R Littman · New York University School Of Medicine · R01 · FY2021 · CA
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$572,168Dan R Littman · New York University School Of Medicine · R01 · FY2025 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy.
$572,160Mary L. Disis · University Of Washington · R01 · FY2010 · CA
The connection of innate and adaptive anti-cancer immunity
$572,121John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Photon-counting X-ray and Optical Tomography for Preclinical Cancer Research
$572,090Ge Wang · Rensselaer Polytechnic Institute · R01 · FY2022 · CA
Microenvironmental Control of Capillary Morphogenesis
$572,021Andrew J Putnam · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia
$571,959Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2022 · HL
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma
$571,954Erik Sulman · New York University School Of Medicine · R01 · FY2021 · CA
Mechanisms of Tumor Cell Dormancy and Tumor Recurrence
$571,893Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
$571,835Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2025 · NS
Progesterone Receptor (PR) Signaling Cross Talk Drives ER+ Breast Cancer
$571,826Carol Ann Lange · University Of Minnesota · R01 · FY2024 · CA
A novel AR degrader in castrate-resistant prostate cancer
$571,810Hyeong-Reh Choi Kim · Wayne State University · R01 · FY2024 · CA
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1
$571,785David Andrew Largaespada · University Of Minnesota · R01 · FY2023 · NS
CAREER: Probing the Physiochemical Regulators of Tumor Stroma Interactions Using Microfluidic Biomimicry
$571,753Jonathan W Song · Ohio State University, The · · FY2018 · ENG
Adoptive T Cell Therapy for the Treatment of HER2 Overexpressing Cancers
$571,699Mary L. Disis · University Of Washington · R01 · FY2008 · CA
Engineering immunotherapeutic probiotics to mitigate irAE
$571,668Tal Danino · Columbia Univ New York Morningside · U01 · FY2024 · CA
3-D spatial approach to discover genomic effectors of immunosuppression during malignant transformation
$571,644Joseph F Costello · University Of California, San Francisco · R01 · FY2021 · CA
Developmental pathways regulating adult lung quiescence
$571,587Edward E Morrisey · University Of Pennsylvania · R01 · FY2017 · HL
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene
$571,567Dan Mercola · University Of California-Irvine · U01 · FY2014 · CA
Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer
$571,496Jianmin Zhang · University Of Toledo Health Sci Campus · R01 · FY2024 · CA
Single Cell Methods for Bioeffector Discovery and Analysis
$571,471Brian O Bachmann · Vanderbilt University · R01 · FY2022 · CA
Elucidating the Role of Cancer-Associated FGL1 in Tumor Immunity and Developing FGL1-Guided Anti-LAG-3 Cancer Immunotherapy
$571,456Jun Wang · New York University School Of Medicine · R37 · FY2025 · CA
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma
$571,434David Charles Lyden · Weill Medical Coll Of Cornell Univ · U01 · FY2015 · CA
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance
$571,380Stephen H Safe · Texas A&M University · R01 · FY2025 · CA
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
$571,193T.-C. Wu · Johns Hopkins University · R01 · FY2022 · CA